New heart solution tested in Kids' surgery: could it be safer?
NCT ID NCT07381530
First seen Feb 02, 2026 · Last updated Jun 22, 2026 · Updated 17 times
Summary
This study compares two solutions, Custodiol and Custodiol-N, used to protect the heart during surgery in children with congenital heart defects. About 100 children will be randomly assigned to receive one of the two solutions. The goal is to see which one is safer and better at preventing heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART MALFORMATIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Deutsches Herzzentrum München, TUM Universitätsklinikum, Klinik für Chirurgie angeborener Herzfehler und Kinderherzchirurgie
München, 80636, Germany
-
Universitätsklinikum Gießen und Marburg GmbH, Abteilung für Kinderherzchirurgie und angeborene Herzfehler
Giessen, 35385, Germany
-
Universitätsklinikum Münster, Klinik für Herz- und Thoraxchirurgie,Sektion Kinderherzchirurgie
Münster, 48149, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Custodiol-N and Custodiol (heart-protecting solutions used during surgery)
What this could lead to
If Custodiol-N proves safer or more protective, it could become the preferred solution for children undergoing heart surgery, potentially reducing complications.
What could go wrong
This is a phase II trial with only 100 participants, and it is currently suspended. Results may not confirm superiority, and the study may not be completed.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.